None listed
Conditions
Brief summary
The prevalence of obesity has increased substantially globally in the past few decades. Our current obesogenic environment is characterized by the abundance of highly palatable and high energy dense foods, which promotes people to overeat and could lead to positive energy balance over time. The consumption of low energy dense foods such as non-nutritive sweeteners has the potential to reduce total energy intake and aids in body weight management. Two natural non-nutritive sweeteners (i.e. Stevia and Luo Han Guo) have recently been approved by the U.S. Food and Drug Administration. To our knowledge, no studies to date have compared the effects of consuming different types of sweeteners, particularly Luo Han Guo, on postprandial glucose and energy compensation in humans. Therefore the objective of this study is to examine the effects of consuming four different types of sweeteners (sucrose, aspartame, Stevia, and Luo Han Guo) in liquid form on postprandial glucose and insulin concentrations, and dietary compensation among Asians. The proposed study will provide novel insights regarding the glycaemic, insulinaemic, and satiety responses to nutritive and non-nutritive sweeteners.
Interventions
This study will be conducted using a randomised crossover design with four treatments: sucrose, aspartame, Stevia, and Luo Han Guo. The dosage used in the present study is the dose commonly found in commercial products and all the treatments are matched for sweetness, e.g. 1). 65 g sucrose in 500 mL water; 2). 0.44 g aspartame in 500 mL water; 3). 0.33 g Stevia in 500 mL water; 4). 0.63 g Luo Han Guo in in 500 mL water. All potential participants will be asked to attend a screening session after a 10-hour overnight fast for consenting and screening procedures. Some basic anthropometric measurements such as height, weight, waist and hip circumferences will be taken. Body composition will be measured using Tanita BC-418 machine and BODPOD. Blood pressure will be taken using an automated blood pressure monitor. After the screening visit, participants will be asked to attend four test sessions, with a minimum of five-day washout period between the test sessions. During each test day, participants will be asked to consume a pre-package study breakfast in the morning. The study breakfast consists of a packet of Milo, an apple, a packet of biscuit, and a muesli bar. They will be asked to consume a study preload (e.g. sucrose, aspartame, Stevia or Luo Han Guo drink) within fifteen minutes in mid morning and they will be provided with an ad libitum lunch an hour later, where they are allowed to consume as much or as little food as they wish. Fingerprick blood samples will be obtained at baseline (prior to preload consumption), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, and 180 minutes after the commencement of preload consumption. Participants will be asked to complete an appetite-rating questionnaire at the same time points. All participants will be asked to complete a physical activity questionnaire and one-day diet record a day before their test day and the actual test day. Participants will also be given the option whether they would like to have their blood glucose to be monitored the day before and after each test session. If they take up this option, Continuous Glucose Monitoring System (CGMS) insertion will be carried out by a trained researcher the day before each test session and they will return to CNRC on Day 3 for CGMS removal. The sensor will be calibrated using finger prick capillary blood glucose measurements taken at pre-meals (breakfast, lunch, snack, dinner) and before sleeping during the intervention period with the OneTouchUltra'Registered Trademark'2 blood glucose meter (LifeScan,Inc., Milpitas, CA, USA).
Sponsors
Study design
Eligibility
Inclusion criteria
The inclusion criteria for this study are healthy males aged between 21 and 50 years.
Exclusion criteria
The exclusion criteria are as follows, (a) People with major chronic disease such as heart disease, cancer or diabetes mellitus (b) Individuals whose body weight has changed more than 5 kilograms in the last 12 months (c) People who are taking insulin or medications known to affect glucose metabolism, appetite or energy metabolism (d) Individuals who are currently dieting (e) People with intolerance or allergy to study foods